Evaluation of the Quality of Life in Moroccan Patients Diagnosed with Hypoparathyroidism

Table 3

QoL of patients with chronic HPt.

Variables	Number (%) (N = 143)	Total score SF-36 (mean ± SD)	value
Age >60 years	109 (76.3%)	38.08 ± 13.62	<0.001
Age ≤60 years	34 (23.7%)	49.67 ± 14.7
Gender: male	19 (13.8%)	42.08 ± 13.7	0.76
Gender: female	124 (86.7%)	43.23 ± 11.12
Marital status: single	24 (16.8%)	45.12 ± 14.2	0.45
Marital status: married	119 (83.2%)	43.34 ± 10.6
Postsurgical etiology	128 (89.5%)	41.32 ± 5.72	0.004
Nonsurgical etiology	15 (10.5%)	50.13 ± 7.12
Dose of calcium/day ≥2 g/day	109 (76.2%)	49.1 ± 3.3	0.013
Dose of calcium/day <2 g/day	34 (23.8%)	43.2 ± 8.6
Dose of alfacalcidol/day ≥1.5 μg/day	111 (77.6%)	47.1 ± 3.15	0.012
Dose of alfacalcidol/day <1.5 μg/day	32 (22.4%)	40.4 ± 6.72
The duration of disease: ≤10 years	85 (59.4%)	46.2 ± 8.3	0.82
The duration of disease: >10 years	58 (40.6%)	44.7 ± 7.9
Normocalcemia: yes	101 (70.6%)	47.7 ± 9.72	0.69
Normocalcemia: no	42 (29.4%)	46.5 ± 10.15
Therapeutic compliance: yes	99 (69.2%)	49.6 ± 5.72	<0.031
Therapeutic compliance: no	44 (30.8%)	41.3 ± 4.15

HPt: hypoparathyroidism. Bold values represent significant p values.